{
  "retracted": false,
  "timestamp": 1388534400000,
  "updates": [
    {
      "timestamp": 1496004161514,
      "identifier": {
        "doi": "10.1016/j.clim.2013.11.001"
      },
      "type": "err"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.clim.2011.10.010"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to ‘A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption’ [Clin. Immunol. 142 (2012) 252–268]"
}
